XML 53 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Schedule of Diluted Earnings Per Common Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Accounting Policies [Abstract]    
Net income (loss) attributable to Harrow Health, Inc. $ 11,358 $ (3,513)
Denominator – weighted average number of shares outstanding, basic 24,841,386 20,949,199
Dilutive common equivalent shares 1,748,309
Number of shares used for diluted earnings per share computation 26,589,695 20,949,199
Net income (loss) per share, diluted $ 0.43 $ (0.17)